Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice
about
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.Comparative analysis of four terpenoids in root and cortex of Tripterygium wilfordii Radix by different drying methodsTherapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.(5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling.Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus.Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.Detoxication mechanisms of Radix Tripterygium wilfordii via compatibility with Herba Lysimachia christinae in S180-bearing mice by involving Nrf2.
P2860
Q36126483-63AFD837-5BD5-4A15-BCF4-78E5B5E53CE3Q36203021-EE708BD5-CAA9-4C5F-B3FD-516C5C44B1D0Q36295343-BE5AC2DA-6ABB-43DD-BBF6-631D3FEF22AEQ36577793-4F564B92-CC38-4380-B1AB-10432DAF8A68Q36870048-31E10997-2F14-4C0A-8DCD-3CC3C0576DAEQ38720673-39F4269B-3C56-42E0-8C82-55461C43959DQ40054103-3F7077EE-3E83-4EAD-9D9A-D6A8E2E78B07Q47155691-847FEA12-8277-447C-918A-F113A4772C82Q51477256-8E707295-CAC6-4B65-974F-DCA0A92E420EQ55717443-2AFFBAA3-D333-481A-8B5F-00155A9B68CC
P2860
Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@ast
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@en
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@nl
type
label
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@ast
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@en
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@nl
prefLabel
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@ast
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@en
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@nl
P2093
P2860
P356
P1476
Therapeutic impact of the ethy ...... on nephritis in NZB/W F1 mice
@en
P2093
Nancy S Longo
Peter E Lipsky
Victoria Hoffmann
Xuelian Tao
P2860
P2888
P356
10.1186/AR1879
P577
2006-01-03T00:00:00Z
P5875
P6179
1003799538